These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 35730680)

  • 1. Rings in Clinical Trials and Drugs: Present and Future.
    Shearer J; Castro JL; Lawson ADG; MacCoss M; Taylor RD
    J Med Chem; 2022 Jul; 65(13):8699-8712. PubMed ID: 35730680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining Molecular Scaffolds from FDA Approved Drugs: Application to Drug Discovery.
    Taylor RD; MacCoss M; Lawson AD
    J Med Chem; 2017 Mar; 60(5):1638-1647. PubMed ID: 27935308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rings in drugs.
    Taylor RD; MacCoss M; Lawson AD
    J Med Chem; 2014 Jul; 57(14):5845-59. PubMed ID: 24471928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two- and three-dimensional rings in drugs.
    Aldeghi M; Malhotra S; Selwood DL; Chan AW
    Chem Biol Drug Des; 2014 Apr; 83(4):450-61. PubMed ID: 24472495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repurposing of FDA approved ring systems through bi-directional target-ring system dual screening.
    Kumar S; Jang C; Subedi L; Kim SY; Kim MH
    Sci Rep; 2020 Dec; 10(1):21133. PubMed ID: 33273509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magic Rings: Navigation in the Ring Chemical Space Guided by the Bioactive Rings.
    Ertl P
    J Chem Inf Model; 2022 May; 62(9):2164-2170. PubMed ID: 34445865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring clinical trial transparency: an empirical analysis of newly approved drugs and large pharmaceutical companies.
    Miller JE; Wilenzick M; Ritcey N; Ross JS; Mello MM
    BMJ Open; 2017 Dec; 7(12):e017917. PubMed ID: 29208616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Publication of clinical trials supporting successful new drug applications: a literature analysis.
    Lee K; Bacchetti P; Sim I
    PLoS Med; 2008 Sep; 5(9):e191. PubMed ID: 18816163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploiting cheminformatic and machine learning to navigate the available chemical space of potential small molecule inhibitors of SARS-CoV-2.
    Kumar A; Loharch S; Kumar S; Ringe RP; Parkesh R
    Comput Struct Biotechnol J; 2021; 19():424-438. PubMed ID: 33391634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of heterocyclic rings through quantum chemical topology.
    Griffiths MZ; Popelier PL
    J Chem Inf Model; 2013 Jul; 53(7):1714-25. PubMed ID: 23795608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Computational Approach to Predict Off-Target Interactions for Small Molecules.
    Rao MS; Gupta R; Liguori MJ; Hu M; Huang X; Mantena SR; Mittelstadt SW; Blomme EAG; Van Vleet TR
    Front Big Data; 2019; 2():25. PubMed ID: 33693348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs.
    Mao F; Ni W; Xu X; Wang H; Wang J; Ji M; Li J
    Molecules; 2016 Jan; 21(1):75. PubMed ID: 26771590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder: a systematic review and exploratory meta-analysis.
    De Hert M; Yu W; Detraux J; Sweers K; van Winkel R; Correll CU
    CNS Drugs; 2012 Sep; 26(9):733-59. PubMed ID: 22900950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virtual Exploration of the Ring Systems Chemical Universe.
    Visini R; Arús-Pous J; Awale M; Reymond JL
    J Chem Inf Model; 2017 Nov; 57(11):2707-2718. PubMed ID: 29019686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postapproval studies of drugs initially approved by the FDA on the basis of limited evidence: systematic review.
    Pease AM; Krumholz HM; Downing NS; Aminawung JA; Shah ND; Ross JS
    BMJ; 2017 May; 357():j1680. PubMed ID: 28468750
    [No Abstract]   [Full Text] [Related]  

  • 18. Publication statuses of clinical trials supporting FDA-approved immune checkpoint inhibitors: a meta-epidemiological investigation.
    Omae K; Kataoka Y; Tsujimoto Y; Tsutsumi Y; Yamamoto Y; Fukuhara S; Furukawa TA
    BMC Cancer; 2019 Oct; 19(1):998. PubMed ID: 31651263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers and biometric measures of adherence to use of ARV-based vaginal rings.
    Stalter RM; Moench TR; MacQueen KM; Tolley EE; Owen DH;
    J Int AIDS Soc; 2016; 19(1):20746. PubMed ID: 27142091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heteroaromatic rings of the future.
    Pitt WR; Parry DM; Perry BG; Groom CR
    J Med Chem; 2009 May; 52(9):2952-63. PubMed ID: 19348472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.